Macon Staples, who was recently diagnosed with B-Cell Acute Lymphoblastic Leukemia, was welcomed home with a parade in Pell ...

Marlise R. Luskin, MD, MSCE, speaks with Healio about findings from the phase 3 randomized Alliance A041501 trial.The study was put on hold due to grade 5 events among patients who received inotuzumab ...

Ongoing clinical trials focused on TEG001 (a hyperactive Vγ9Vδ2 TCR variant, NTR6541) indicate that AMPK agonist treatment heightened the sensitivity of breast cancer organoids and Duodi cells (a ...

In recent years, several important advances have been made in our understanding of the pathways that lead to cell dysfunction and death in Parkinson's disease (PD) and Huntington's disease (HD).

University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage. If approved ...

Precursor B-cell acute lymphoblastic leukemia is a fast-growing leukemia that affects early B cells in bone marrow. It’s both more common and has a better outlook in children. Leukemia is a type ...

The NOTCH1 receptor is a class I heterodimeric transmembrane protein comprised of an extracellular and a transmembrane subunit which in the resting receptor are noncovalently associated through a ...

The NCLs (neuronal ceroid lipofuscinosis) are pediatric neurodegenerative disorders. The nine clinical variants are caused by mutations in different genes (CLN1–CLN9). Six of the genes are ...

Coping with a diagnosis of acute lymphoblastic leukaemia (ALL) can be overwhelming. Help and support are available for you and your family. There are things you can do, and specialists who can help ...

In honor of Charley Steven Myers, the Success Bell was created for all MCES students to ring when they accomplish success.

Amgen’s Blincyto (blinatumomab) has been approved by the European Commission (EC) to treat certain acute lymphoblastic leukaemia (ALL) patients earlier in their treatment journey.